Journals in Diseases

6 results in All results

Artificial Intelligence in the Life Sciences

• ISSN: 2667-3185

Providing a scientific forum for practical applications and theoretical advances of Artificial Intelligence (AI) in the life sciences and related disciplines including (but not restricted to):New AI methods for life science researchAdaptation of existing AI concepts for life science applicationsApplication of AI approaches in: Molecular and systems biologyPopulation and disease geneticsBio- and cheminformaticsMedicinal chemistry, chemical biology, and drug discoveryMedical researchPublications are required to contain substantial AI and life science components. Clinical studies reporting routine diagnostic efforts hall outside the scope of AILSCI.Background: Artificial Intelligence originates from computer science and covers a wide range of approaches intended to enhance the ability of machines to make data-driven decisions and accurate predictions of events. In many scientific fields, AI is being increasingly considered and integrated, especially in the context of Big Data. Given their complexity and highly interdisciplinary nature, the life sciences provide ample opportunities for AI to impact R&D efforts in a variety of ways.Key words: Artificial Intelligence; Life Sciences; Drug Discovery; Bio- and Cheminformatics, Machine Learning; Machine Intelligence; Deep Learning; Data Mining; Big Data.

Subscribe

Digital Chinese Medicine

• ISSN: 2589-3777

Digital Chinese Medicine (DCM) is a new, quarterly, open-access global publication, officially funded by the Project for Enhancing the International Impact of China STM Journals —2016.With the aim of promoting the combination of TCM (Traditional Chinese Medicine) and modern information science and realizing modernization, this new journal provides an important platform for the communication of scientific and technological TCM.Spanning all aspects in the multidisciplinary fields of TCM, Chinese materia medica, and computer and information sciences, this journal publishes a range of article types, including highlights, reviews, and original research.Editorial Board

Subscribe

Heliyon

• ISSN: 2405-8440
• 5 Year impact factor: 3.9
• Impact factor: 3.4

Heliyon considers research from all areas of the physical, applied, life, social and medical sciences. We publish manuscripts reporting scientifically accurate and valuable research, which adheres to accepted ethical and scientific publishing standards. As such Heliyon publishes new insights as well as extensions on existing theories, negative/null results and replication studies.Submissions covering arts, humanities and law are not considered in Heliyon. Authors of these submissions are encouraged to submit directly to our partner journal Social Sciences & Humanities Open.Heliyon classifies manuscripts/articles into different sections based on the research topic discussed. Some sections exclude certain types of studies from their scope. To know more and to see the kind of manuscripts the various sections publish, please visit: https://www.cell.com/heliyon/sectionsA dedicated in-house editorial office team, internal editors as well as external academic section and associate editors handle your manuscript and manage the publication process, giving your research the editorial support and quality control it deserves.If it's important to you, it's important to us. Submit your paper today.

Subscribe

Rare

• ISSN: 2950-0087

The Official Journal of the Undiagnosed Diseases Network International.Rare. Open Research in Rare Diseases is an open-access, multidisciplinary, international journal that aims to have a clinical impact on rare disease patients. It publishes rigorously peer-reviewed articles on research that improves the well-being and quality of life of patients with rare diseases - diagnosed or undiagnosed - and their families. The journal has a broad scope, including but not limited to:-Direct clinical and psychosocial care: diagnosis, follow-up, treatment, therapeutic advances, clinical trials, quality of life-Increasing diagnostic yield and early diagnosis: implementation of new DNA techniques, provision of genetic tests and newborn screening-Pharmacology: development and regulation of orphan drugs-Application of technologies to diagnose or interpret genetic variants-Health economics and public policies: regulatory, reimbursement policies-Legal perspectives: data sharing, privacy issues-Ethics: primary prevention and family information-Patient contributions to research: late diagnosis (patient journey)-International collaborative projects, initiatives by associations and the rare disease community.The journal is open in every sense: patients are encouraged to contribute with their experiences and needs, as they are one of the pillars of medical research.Publication formats include full-length research articles, reviews, case reports, correspondence, short communications, and commentaries.

Subscribe

The Journal of Prevention of Alzheimer's Disease

• ISSN: 2274-5807

The Journal of Prevention of Alzheimer’Disease (JPAD) is a e-only gold open access journal that publishes reviews, original research articles and short reports to improve the knowledge in the field of Alzheimer prevention including: neurosciences, biomarkers, imaging, epidemiology, public health, physical cognitive exercise, nutrition, risk and protective factors, drug development, trials design, and heath economic outcomes.JPAD publishes also the meeting abstracts from the Clinical Trial on Alzheimer Disease - CTAD's event.The Journal of Prevention of Alzheimer’Disease is indexed in MEDLINE, SCIE (WoS), Scopus, and ranked in its categories in the first quartile (Q1) in both SCIE (WoS) and Scopus databases.

Subscribe

URINE

• ISSN: 2590-2806

URINE promotes basic research, translation and clinical applications in the area of urine, with the aim of improving understanding, screening, diagnosis, treatment monitoring and disease management. The journal not only accelerates the development of research in this field but helps to build connections between the diverse communities involved in urine research.The next generation of biomarker is projected to rely heavily upon urinary biomarkers to stratify risk, diagnose disease, determine optimal treatment strategies, evaluate drug response and monitor disease progression.These objectives are achieved by providing a fast, author-focused publication process. All types of papers are welcome, and each submission benefits from expert peer-review. To protect the novelty of authors, URINE encourages and welcomes the submission of manuscripts that have already been posted on a preprint archive.Submissions on a variety of urine-related topics will be considered. These include, but are not limited to, papers addressing:Urinary biomarker discovery and validation and the development of various systematic diseases.Disease development observations from changes in urine.Screening for early signs of pathophysiological processes in the body.Disease management and treatment based on early diagnosis of the diseases in urine.Technological developments that can potentially be applied to the field of urine, either in basic research or clinical applications, for example, biobanking methods of various urine components.Bioinformatics related to urinary biomarker studies.Urinary extracellular vesiclesUrinary-based liquid biopsiesIn recognition of the breadth of the research communities active in biomarker studies, the URINE Executive Editorial board will consist of four types of researchers at all times:Clinical domain expertsExperts in physiology, biology, biochemistry and related disciplinesStatistical and experimental design expertsEngineering expertsThis will help to ensure that the journal can reliably evaluate a range of studies and maintain a diverse collection of articles.

Subscribe